Generating business value through analytics
Pharma analytics
Pharma Analytics provides quick access to critical business insights, easy data comprehension for decision support, and near real-time reporting. It helps your business generate value through analytics.
Life science–Snapshot of the Indian market
The size of India’s pharmaceuticals market is US$20.49 billion in 2018. It is estimated to reach US$52.61 billion by the end of 2028.
Domestic active Pharma ingredients (API) consumption is expected to reach US$18.8 billion by FY2021. The domestic generics market is expected to reach US$39.1 billion by 2028.
India is the world’s largest provider of generic medicines; the country’s generic drugs account for 20% of the global generic drug exports (in terms of volume).
Generic drugs with a 70% market share form the largest segment of the Indian pharmaceutical sector. Over-the-counter (OTC) medicines constitute about 21% of the market, while patented drugs have a 9% share.